forgot password?

  • Visitor Edition

 

Health Care, Pharmaceuticals Article, prescription drug
Premium Content
Article at a glance:

Swiss drug makers: Facing the US giants

During the past five years, the global pharmaceutical industry has experienced a golden age of wealth creation, defined as total returns to shareholders—that is, the value of stocks and dividends (Exhibit 1). Swiss companies, which outperformed both the global stock market benchmark an...

subscribe now to read this article

This article is available to Premium Members only.

Explore "Additional Thinking" to find hundreds of related, free articles.

Additional Thinking

This Week's Featured Article
Health Care, Pharmaceuticals , Identifying savings opportunities investment banks
Identifying the savings opportunities at investment banks

US investment banks are cutting costs by shrinking employment, but they can trim other types of spending without causing serious damage to their culture or morale.

Abstract

Search full site

This article is available to Premium Members only. Please subscribe below.

Already a Quarterly member? Log in now.
Are you a Firm member or alumnus?

Premium Membership benefits:

  • Unlimited site access, including McKinsey's latest thinking and enduring business ideas from the archive
  • Subscription to the collector's edition print journal
  • Downloadable PDFs of all articles for offline use

Premium Membership FAQs

Start by filling in this form

  • 1. Membership Information
  • 2. Shipping, Billing, & Payment
  • 3. Review & Complete

Country & Membership Term

Shipping & Handling covers all charges for your membership term.

You may pay with Visa, MasterCard, Discover, or American Express.

Member Information

View our privacy policy.

We will not share your e-mail.
See details.

Newsletter Sign-up

*Required